Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

Byeong‐Keuk Kim(Ewha Womans University), Myeong‐Ki Hong(Ulsan College), Kyeong Ho Yun(Wonkwang University Hospital), Sung‐Jin Hong(Inje University Sanggye Paik Hospital), Donghoon Choi(Korea Institute of Science & Technology Information), Jung Ho Heo(Kosin University), Soon Jun Hong(Korea University), Seung‐Woon Rha, Young‐Guk Ko(Yonsei University), Chul‐Min Ahn(Yonsei University), Yun‐Hyeong Cho(Hanyang University), Seung‐Jun Lee(Yonsei University), Jung‐Sun Kim(Yonsei University), Bum‐Kee Hong(Severance Hospital), Yong‐Joon Lee(Severance Hospital), Yangsoo Jang(Yonsei University)
The Lancet
July 1, 2022
Cited by 304


Related Papers